• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 38
  • 12
  • 8
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • Tagged with
  • 91
  • 91
  • 12
  • 12
  • 12
  • 12
  • 12
  • 11
  • 11
  • 9
  • 9
  • 9
  • 9
  • 8
  • 8
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
41

Pattern searches for the identification of putative lipoprotein genes in Gram positive bacterial genomes

Harrington, Dean J., Sutcliffe, I.C. 01 July 2002 (has links)
No / N-terminal lipidation is a major mechanism by which bacteria can tether proteins to membranes and one which is of particular importance to Gram-positive bacteria due to the absence of a retentive outer membrane. Lipidation is directed by the presence of a cysteine-containing `lipobox' within the lipoprotein signal peptide sequence and this feature has greatly facilitated the identification of putative lipoproteins by gene sequence analysis. The properties of lipoprotein signal peptides have been described previously by the Prosite pattern PS00013. Here, a dataset of 33 experimentally verified Gram-positive bacterial lipoproteins (excluding those from Mollicutes) has been identified by an extensive literature review. The signal peptide features of these lipoproteins have been analysed to create a refined pattern, G+LPP, which is more specific for the identification of Gram-positive bacterial lipoproteins. The ability of this pattern to identify probable lipoprotein sequences is demonstrated by a search of the genome of Streptococcus pyogenes, in comparison with sequences identified using PS00013. Greater discrimination against likely false-positives was evident from the use of G+LPP compared with PS00013. These data confirm the likely abundance of lipoproteins in Gram-positive bacterial genomes, with at least 25 probable lipoproteins identified in S. pyogenes
42

"Determinação de alvos antigênicos na doença reumática cardíaca utilizando phage display" / Identification of molecular markers involved in the pathogenesis of rheumatic heart disease by phage display

Bessa, Juliana Mattos de Almeida 11 January 2006 (has links)
Pacientes com doença reumática cardíaca (DRC) desenvolvem lesões valvares mediadas por linfócitos T CD4+, capazes de reconhecer cruzadamente proteínas cardíacas e estreptocócicas pelo mecanismo de mimetismo molecular. Neste trabalho empregamos uma biblioteca peptídica de Phage Display para identificar auto-antígenos cardíacos capazes de serem reconhecidos por duas linhagens intralesionais de linfócitos T e um clone derivado de uma das linhagens isolados de pacientes com DRC. A análise dos peptídeos dos fagos em banco de dados de proteínas revelou novos epitopos da miosina cardíaca, laminina, vimentina e outras proteínas coiled-coil, provavelmente involvidos no processo auto-imune da DRC. Outras moléculas inflamatórias como citocinas, integrinas e fatores de crescimento também foram identificadas / Rheumatic heart disease (RHD) patients develop valvar lesions with CD4+ T lymphocytes infiltrating the heart. Molecular mimicry between streptococcal and cardiac proteins recognized by these T cells may explain these auto-aggressive lesions. In the present work we used a Phage Display peptide library to identify cardiac antigens which could be recognized by two heart infiltrate T cell lines and by a T cell clone derived from one of the lines which were isolated from RHD patients. Using the protein data bank to analyse the phage peptides, we observed that many sequences showed homology with cardiac myosin, laminin, vimentin and other coiled-coil proteins, suggesting the involvement of these proteins in the autoimmune process of RHD. Other inflammatory molecules such as cytokines and integrins were also identified
43

"Determinação de alvos antigênicos na doença reumática cardíaca utilizando phage display" / Identification of molecular markers involved in the pathogenesis of rheumatic heart disease by phage display

Juliana Mattos de Almeida Bessa 11 January 2006 (has links)
Pacientes com doença reumática cardíaca (DRC) desenvolvem lesões valvares mediadas por linfócitos T CD4+, capazes de reconhecer cruzadamente proteínas cardíacas e estreptocócicas pelo mecanismo de mimetismo molecular. Neste trabalho empregamos uma biblioteca peptídica de Phage Display para identificar auto-antígenos cardíacos capazes de serem reconhecidos por duas linhagens intralesionais de linfócitos T e um clone derivado de uma das linhagens isolados de pacientes com DRC. A análise dos peptídeos dos fagos em banco de dados de proteínas revelou novos epitopos da miosina cardíaca, laminina, vimentina e outras proteínas coiled-coil, provavelmente involvidos no processo auto-imune da DRC. Outras moléculas inflamatórias como citocinas, integrinas e fatores de crescimento também foram identificadas / Rheumatic heart disease (RHD) patients develop valvar lesions with CD4+ T lymphocytes infiltrating the heart. Molecular mimicry between streptococcal and cardiac proteins recognized by these T cells may explain these auto-aggressive lesions. In the present work we used a Phage Display peptide library to identify cardiac antigens which could be recognized by two heart infiltrate T cell lines and by a T cell clone derived from one of the lines which were isolated from RHD patients. Using the protein data bank to analyse the phage peptides, we observed that many sequences showed homology with cardiac myosin, laminin, vimentin and other coiled-coil proteins, suggesting the involvement of these proteins in the autoimmune process of RHD. Other inflammatory molecules such as cytokines and integrins were also identified
44

Structure d'une tagatose-1,6-bisphosphate aldolase de classe I : étude d'une apparente perte de stéréospécificité

LowKam, Clotilde 10 1900 (has links)
La tagatose-1,6-biphosphate aldolase de Streptococcus pyogenes est une aldolase de classe I qui fait montre d'un remarquable manque de spécificité vis à vis de ses substrats. En effet, elle catalyse le clivage réversible du tagatose-1,6-biphosphate (TBP), mais également du fructose-1,6-biphosphate (FBP), du sorbose-1,6-biphosphate et du psicose-1,6-biphosphate, quatre stéréoisomères, en dihydroxyacétone phosphate (DHAP) et en glycéraldéhyde-3-phosphate (G3P). Afin de mettre à jour les caractéristiques du mécanisme enzymatique, une étude structurale de la TBP aldolase de S. pyogenes, un pathogène humain extrêmement versatile, a été entreprise. Elle a permis la résolution de la structure native et en complexe avec le DHAP, a respectivement 1.87 et 1.92 Å de résolution. Ces mêmes structures ont permis de se représenter plus clairement le site actif de l'enzyme en général, et les résidus catalytiques en particulier. Le trempage des cristaux de TBP aldolase dans une solution saturante de DHAP a en outre permis de piéger un authentique intermédiaire iminium, ainsi que sa géométrie particulière en atteste. Des expériences d'échange de proton, entreprises afin d'évaluer le stéréoisomérisme du transfert de proton catalytique, ont également permis de faire une intéressante découverte : la TBP aldolase ne peut déprotoner le coté pro-R du C3 du DHAP, mais peut le protonner. Ce résultat, ainsi que la comparaison de la structure du complexe TBP aldolase-DHAP avec la structure du complexe FBP aldolase de muscle de lapin- DHAP, pointe vers un isomérisme cis-trans autour du lien C2-C3 de la base de Schiff formée avec le DHAP. De plus, la résolution de ces deux structures a permis de mettre en évidence trois régions très mobiles de la protéine, ce qui pourrait être relié au rôle postulé de son isozyme chez S. pyogenes dans la régulation de l’expression génétique et de la virulence de la bactérie. La cristallographie par rayons X et la cinétique enzymatique ont ainsi permis d'avancer dans l'élucidation du mécanisme et des propriétés structurales de cette enzyme aux caractéristiques particulières. / Tagatose-1,6-biphosphate aldolase from Streptococcus pyogenes is a class I aldolase that shows a lack of stereospecificity that is rare in enzymes in general, and in aldolases in particular. This aldolase catalyzes the reversible cleavage of tagatose-1,6-biphosphate (TBP), fructose-1,6-biphosphate (FBP), sorbose-1,6-biphosphate and psicose-1,6-biphosphate, four stereoisomers, in dihydroxyacetone phosphate and glyceraldehyde-3-phosphate (DHAP). In order to understand its mechanism, a structural study of TBP aldolase from S. pyogenes, one of the most versatile and virulent human pathogen, was initiated and high resolution crystallographic structures of native and DHAP-liganded TBP aldolase were solved. These structures allowed us to gain informations regarding active site residues implicated in catalysis and that give rise to the apparent lack of specificity. Soaking of TBP aldolase crystals in saturating DHAP solution specifically trapped the iminium intermediate, as demonstrated by its geometry. Furthermore, proton transfer studies uncovered an interesting phenomenon: TBP aldolase from S. pyogenes is unable to detritiate pro-R labelled hydrogen position at C3 of DHAP, yet it is able to tritiate both the pro-R and the pro-S position. These results, taken together with the superposition of the DHAP-TBP aldolase with the DHAP-FBP aldolase from rabbit muscle, suggest a cis-trans isomerism about the Schiff base C2-C3 bond. The resolution of both the native and the liganded structure also proved useful in identifying three very mobile regions in the protein. This trend could be linked to the putative metabolic sensor and genetic expression regulator role of LacD.1 in S. pyogenes. X-rays crystallography and traditional enzymatic kinetics allowed us to gain insights into the catalytic mechanism and others structural properties of this important metabolic enzyme.
45

Febre reumática: um modelo animal para uma vacina humana / Rheumatic fever: an animal model for a human disease

Alcantara, Flavio Ferraz de Paes e 28 August 2006 (has links)
A febre reumática é um bom exemplo de uma doença auto-imune deflagrada por um processo infeccioso. Num prazo de uma a quatro semanas após a resolução de uma faringite não tratada por cepas reumatogênicas de S. pyogenes, o organismo de um hospedeiro susceptível desencadeia uma resposta imune contra grandes articulações, coração, tecidos subcutâneos e cérebro. Acredita-se que elementos presentes na bactéria e reconhecidos durante a infecção na orofaringe, sejam confundidos com estruturas próprias do organismo, num processo denominado mimetismo molecular. Entre as proteínas envolvidas na reação cruzada, encontram-se a miosina cardíaca, pelo lado do hospedeiro, e a proteína M do microorganismo invasor. Esta última (proteína M) tem sido extensamente estudad. É a base da classificação das cepas de S. pyogenes e importante fator de virulência. Também tem sido explorada como imunógeno em várias estratégias vacinais. O estudo desta patologia tem sido dificultado pela ausência de um modelo animal que reproduza aspectos fundamentais da patologia humana, entre estes as lesões cardíacas. Uma das razões é o fato de que animais não contraem infecção pelo S. pyogenes. Portanto, produzimos a proteína M1 recombinante e mostramos que a imunização de 28 ratos Lewis por um período de 21 dias ou 14 ratos por 41 dias, com esta proteína foi capaz de induzir resposta inflamatória na maioria dos animais com intensidade variável. Células similares aos nódulos de Aschoff e células de Anitschkow, sugestivas das lesões patognomônicas da febre reumática foram observadas em dias e também de um em quatro dos animais controles que receberam PBS e adjuvantes. Estes resultados sugerem a presença de células auto-reativas no miocárdio dos animais imunizados. Em conclusão, o uso de proteína M1 recombinante como imunógeno em modelo animal de ratos Lewis é capaz de desencadear reação inflamatória em miocárdio e tecido valvular e lesões similares às da febre reumática. O modelo do rato Lewis é até o momento o que apresenta maior semelhança com a doença humana e pode ajudar a esclarecer a imunopatologia da febre reumática. Além disso, certamente será importante para a avaliação do potencial de proteção e de segurança em modelos de vacinas contra o S. pyogenes. / Rheumatic fever is a good example of an autoimmune disease triggered by an infectious process. One to four weeks after the resolution of a non treated pharyngitis caused by rheumatogenic strains of S. pyogenes, the susceptible host unravels an immune response targeting joints, heart, conective tissues and brain. It is thought that molecules present in the bacteria and recognized during the infection at the pharynx are confounded with the organism self structure in a process called ?molecular mimicry?. Amongst the proteins involved in the cross reaction, it may be found cardiac myosin, on the host side, and M protein on the invading organism?s side. The latter (Mprotein) has been extensively studied. It is the basis of the S. pyogenes strains classification, and also an important virulence factor. It has also been explored as an immunogen in several vaccine strategies. The nderstanding of this disease has been hampered by the absence of an animal model that reproduces fundamental aspects of the human pathology, specially cardiac lesions. One of the reasons is the fact that animals do not get infected by S. pyogenes. Hence we have produced the recombinant M1 protein and shown that either the immunization of 28 Lewis rats for a period of 21 days or 14 rats for a period of 41 days, was capable of inducing an inflammatory response in most of the animals with variable intensity. Aschoff nodules-like or Anitschkow-like cells resembling rheumatic fever pathognomonic lesions were seen in 50% of the animals immunized subcutaneously and sacrificed on day 21. We have observed an humoral and cellular response (spleen and lymph node derived cells) specifically targeting M1 protein and the amino (M1AB) and carboxy (M1C) terminus of the protein. However, cross reactions with cardiac myosin were not observer. We have derived T lymphocyte lineages obtained from myocardium infiltrating mononuclear cells from 6 of the 10 animals immunized with M1ABC protein subcutaneously and sacrificed on day 41 and also from one out of four PBS - adjuvant immunized animals. These results suggest the presence of autoreactive cells in the myocardium of the immunized animals. In conclusion, the use of the M1 protein as an immunogen on the Lewis rat model is capable of triggering an inflammatory reaction in the myocardium and valvular tissue and it can produce rheumatic fever like lesions. The Lewis rat model is up to this moment the one to present the highest similarity with human disease. Besides, it will certainly be important on the evaluation of the protection and safety of S. pyogenes vaccines.
46

Análise in vitro da capacidade de cobertura da vacina em desenvolvimento contra  Streptococcus pyogenes / \"in vitro\" analysis of the coverage capacity of the vaccine under development against most frequent strains of Streptococcus pyogenes

De Amicis, Karine Marafigo 08 May 2013 (has links)
O Streptococcus pyogenes (Grupo A de Lancefield) é uma bactéria Gram positiva e beta-hemolítica, responsável por infecções, tais como Faringite, Sepse, Fasciíte Necrotizante e Síndrome do Choque Tóxico Estreptocócico. Indivíduos suscetíveis podem desenvolver sequela não supurativa auto-imune pós-estreptocócica, como a Febre Reumática, Doença Reumática Cardíaca e a Glomerulonefrite Aguda. A proteína M é o principal antígeno bacteriano. Consiste em aproximadamente 450 resíduos de aminoácidos dispostos em quatro regiões (A, B, C e D), contendo alguns blocos de repetições. As regiões C e D são conservadas e a N-terminal (regiões A e B) é polimórfica. Atualmente, existem mais de 250 genótipos de emm conhecidos em todo o mundo, de acordo com o Centers for Disease Control and Prevention. Há vários anos, o desenvolvimento de uma vacina contra S. pyogenes (StreptInCor - identificação médica) foi iniciado, com base na região conservada da proteína M, com o objetivo de proteger o indivíduo vacinado contra infecções estreptocócicas, sem causar reações autoimunes. No presente estudo foi analisada a capacidade \"in vitro\" de anticorpos anti-StreptInCor neutralizarem/opsonizarem as cepas de S. pyogenes mais freqüentes em São Paulo, através da análise do reconhecimento das cepas por soros de camundongos imunizados com StreptInCor. Também foi avaliada por Western blotting a presença de anticorpos de reação cruzada dirigidos ao tecido cardíaco valvular humano. Anticorpos anti-StreptInCor foram capazes de neutralizar/opsonizar, pelo menos, cinco diferentes cepas mostrando que a imunização com StreptInCor pode ser eficaz contra várias cepas de S. pyogenes, assim como prevenir a infecção e sequelas subsequentes, sem causar reações auto-imunes. / Streptococcus pyogenes (Group A) is a Gram positive and beta-hemolytic bacteria, responsible for infections such as Pharyngitis, Sepsis, Necrotizing Fasciitis and Streptococcal Toxic Shock Syndrome. Susceptible individuals may develop post-streptococcal non-suppurative autoimmune sequelae such as Rheumatic Fever, Rheumatic Heart Disease and Acute Glomerulonephritis. The M protein is the major bacterial antigen. It consists of approximately 450 amino acid residues arranged in four regions (A, B, C and D), containing some repeated blocks. C and D regions are conserved and the N-terminus (regions A and B) is polymorphic. Currently there are over 250 known emm genotypes worldwide, according to the Centers for Disease Control and Prevention. Several years ago the development of a vaccine against S. pyogenes (StreptInCor - medical identification) was initiated, based on the M protein conserved region, aiming to protect against streptococcal infections without causing autoimmune reactions. In the present study we analyzed the \"in vitro\" ability of anti-StreptInCor antibodies to neutralize/opsonize the most frequent S. pyogenes strains in Sao Paulo by examining the strains recognition by sera from StreptInCor immunized mice. We also evaluated the presence of cross reactive antibodies directed to the human heart valve tissue by Western blotting. Anti-StreptInCor antibodies were able to neutralize/opsonize at least 5 strains, showing that the immunization with StreptInCor can be effective against several S. pyogenes strains as well as preventing infection and subsequent sequelae, without causing autoimmune reactions.
47

Impacto do uso de técnicas microbiológicas para o estreptococo beta hemolítico do grupo A no diagnóstico e tratamento das faringotonsilites / Impact of the use of microbiological techniques for Group A Streptococcus in the diagnosis and treatment of sore throats

Cardoso, Debora Morais 23 April 2015 (has links)
INTRODUÇÃO: A Faringotonsilite é doença comum nos consultórios e prontosocorros de pediatria. OBJETIVOS: Avaliar o impacto da realização rotineira da prova rápida para pesquisa de estreptococo do grupo A (PRE) no diagnóstico e tratamento da faringotonsilite aguda em crianças e adolescentes atendidos em um Hospital Geral. MÉTODOS: Trata-se de um estudo prospectivo, observacional, de protocolo de atendimento, instituído no Pronto-Socorro do Hospital Universitário da Universidade de São Paulo para o atendimento de crianças e adolescentes com diagnóstico de faringotonsilite aguda. RESULTADOS: Foram estudadas 1039 crianças e adolescentes. Com base no quadro clínico, antibiótico seria prescrito em 530 pacientes (51%), e com o uso da PRE e/ou cultura de orofaringe foi prescrito em 268 (25,8%) pacientes. Das 509 crianças que não receberiam antibiótico pelo quadro clínico, 157 tiveram PRE e/ou cultura de orofaringe positiva. O diagnóstico baseado no quadro clínico apresentou sensibilidade de 63,06% (IC-95%:62,95-63,17%); especificidade de 57,33% (IC-95%:57,25-57,41%); valor preditivo positivo de 50,57% (IC-95%:50,47-50,66%) e valor preditivo negativo de 69,16% (IC-95%: 50,47-50,66%). CONCLUSÕES: Neste estudo o diagnóstico clínico da faringotonsilite estreptocócica mostrou baixa sensibilidade e especificidade. O uso rotineiro da prova rápida para pesquisa de estreptococo permitiu uma redução do uso de antibiótico e a identificação de crianças e adolescentes com faringotonsilite estreptocócicas que não receberiam antibiótico e estariam sob o risco das complicações da infecção estreptocócica / BACKGROUND: Sore throat is a common disease in the pediatric emergency room. OBJECTIVES: The objective of this study was to evaluate the impact of routine performance of rapid antigen detection test (RADT) in the diagnosis and treatment of acute pharyngitis in children treated at an academic hospital. METHODS: This is a prospective, observational, protocol compliance, established at the Emergency of Hospital Universitário - Universidade de São Paulo for the care of children and adolescents diagnosed with acute pharyngitis. RESULTS: We studied 1039 children and adolescents. Based on clinical findings, antibiotic would be prescribed in 530 patients (51%) and using the RADT or sore throat culture was prescribed in 268 patients. Of the 509 children who did not receive antibiotics for the clinical, 157 had positive RADT or sore throat culture. The diagnosis based on clinical sensitivity was 63,06% (IC 95% 62,95- 63,17%), specificity 57,3% (IC 95% 57,25-57,41%), positive predictive value of 50,57% (IC 95% 50,47-50,66%) and negative predictive value of 69,16% (IC 95% 50,47-50,66%). CONCLUSIONS: In this study the clinical diagnosis of streptococcal pharyngitis had low sensitivity and specificity. The routine use of rapid test for streptococcal research led to a reduction of antibiotic use and the identification of a risk group for complication of streptococcal infection
48

Impacto do uso de técnicas microbiológicas para o estreptococo beta hemolítico do grupo A no diagnóstico e tratamento das faringotonsilites / Impact of the use of microbiological techniques for Group A Streptococcus in the diagnosis and treatment of sore throats

Debora Morais Cardoso 23 April 2015 (has links)
INTRODUÇÃO: A Faringotonsilite é doença comum nos consultórios e prontosocorros de pediatria. OBJETIVOS: Avaliar o impacto da realização rotineira da prova rápida para pesquisa de estreptococo do grupo A (PRE) no diagnóstico e tratamento da faringotonsilite aguda em crianças e adolescentes atendidos em um Hospital Geral. MÉTODOS: Trata-se de um estudo prospectivo, observacional, de protocolo de atendimento, instituído no Pronto-Socorro do Hospital Universitário da Universidade de São Paulo para o atendimento de crianças e adolescentes com diagnóstico de faringotonsilite aguda. RESULTADOS: Foram estudadas 1039 crianças e adolescentes. Com base no quadro clínico, antibiótico seria prescrito em 530 pacientes (51%), e com o uso da PRE e/ou cultura de orofaringe foi prescrito em 268 (25,8%) pacientes. Das 509 crianças que não receberiam antibiótico pelo quadro clínico, 157 tiveram PRE e/ou cultura de orofaringe positiva. O diagnóstico baseado no quadro clínico apresentou sensibilidade de 63,06% (IC-95%:62,95-63,17%); especificidade de 57,33% (IC-95%:57,25-57,41%); valor preditivo positivo de 50,57% (IC-95%:50,47-50,66%) e valor preditivo negativo de 69,16% (IC-95%: 50,47-50,66%). CONCLUSÕES: Neste estudo o diagnóstico clínico da faringotonsilite estreptocócica mostrou baixa sensibilidade e especificidade. O uso rotineiro da prova rápida para pesquisa de estreptococo permitiu uma redução do uso de antibiótico e a identificação de crianças e adolescentes com faringotonsilite estreptocócicas que não receberiam antibiótico e estariam sob o risco das complicações da infecção estreptocócica / BACKGROUND: Sore throat is a common disease in the pediatric emergency room. OBJECTIVES: The objective of this study was to evaluate the impact of routine performance of rapid antigen detection test (RADT) in the diagnosis and treatment of acute pharyngitis in children treated at an academic hospital. METHODS: This is a prospective, observational, protocol compliance, established at the Emergency of Hospital Universitário - Universidade de São Paulo for the care of children and adolescents diagnosed with acute pharyngitis. RESULTS: We studied 1039 children and adolescents. Based on clinical findings, antibiotic would be prescribed in 530 patients (51%) and using the RADT or sore throat culture was prescribed in 268 patients. Of the 509 children who did not receive antibiotics for the clinical, 157 had positive RADT or sore throat culture. The diagnosis based on clinical sensitivity was 63,06% (IC 95% 62,95- 63,17%), specificity 57,3% (IC 95% 57,25-57,41%), positive predictive value of 50,57% (IC 95% 50,47-50,66%) and negative predictive value of 69,16% (IC 95% 50,47-50,66%). CONCLUSIONS: In this study the clinical diagnosis of streptococcal pharyngitis had low sensitivity and specificity. The routine use of rapid test for streptococcal research led to a reduction of antibiotic use and the identification of a risk group for complication of streptococcal infection
49

Structure d'une tagatose-1,6-bisphosphate aldolase de classe I : étude d'une apparente perte de stéréospécificité

LowKam, Clotilde 10 1900 (has links)
La tagatose-1,6-biphosphate aldolase de Streptococcus pyogenes est une aldolase de classe I qui fait montre d'un remarquable manque de spécificité vis à vis de ses substrats. En effet, elle catalyse le clivage réversible du tagatose-1,6-biphosphate (TBP), mais également du fructose-1,6-biphosphate (FBP), du sorbose-1,6-biphosphate et du psicose-1,6-biphosphate, quatre stéréoisomères, en dihydroxyacétone phosphate (DHAP) et en glycéraldéhyde-3-phosphate (G3P). Afin de mettre à jour les caractéristiques du mécanisme enzymatique, une étude structurale de la TBP aldolase de S. pyogenes, un pathogène humain extrêmement versatile, a été entreprise. Elle a permis la résolution de la structure native et en complexe avec le DHAP, a respectivement 1.87 et 1.92 Å de résolution. Ces mêmes structures ont permis de se représenter plus clairement le site actif de l'enzyme en général, et les résidus catalytiques en particulier. Le trempage des cristaux de TBP aldolase dans une solution saturante de DHAP a en outre permis de piéger un authentique intermédiaire iminium, ainsi que sa géométrie particulière en atteste. Des expériences d'échange de proton, entreprises afin d'évaluer le stéréoisomérisme du transfert de proton catalytique, ont également permis de faire une intéressante découverte : la TBP aldolase ne peut déprotoner le coté pro-R du C3 du DHAP, mais peut le protonner. Ce résultat, ainsi que la comparaison de la structure du complexe TBP aldolase-DHAP avec la structure du complexe FBP aldolase de muscle de lapin- DHAP, pointe vers un isomérisme cis-trans autour du lien C2-C3 de la base de Schiff formée avec le DHAP. De plus, la résolution de ces deux structures a permis de mettre en évidence trois régions très mobiles de la protéine, ce qui pourrait être relié au rôle postulé de son isozyme chez S. pyogenes dans la régulation de l’expression génétique et de la virulence de la bactérie. La cristallographie par rayons X et la cinétique enzymatique ont ainsi permis d'avancer dans l'élucidation du mécanisme et des propriétés structurales de cette enzyme aux caractéristiques particulières. / Tagatose-1,6-biphosphate aldolase from Streptococcus pyogenes is a class I aldolase that shows a lack of stereospecificity that is rare in enzymes in general, and in aldolases in particular. This aldolase catalyzes the reversible cleavage of tagatose-1,6-biphosphate (TBP), fructose-1,6-biphosphate (FBP), sorbose-1,6-biphosphate and psicose-1,6-biphosphate, four stereoisomers, in dihydroxyacetone phosphate and glyceraldehyde-3-phosphate (DHAP). In order to understand its mechanism, a structural study of TBP aldolase from S. pyogenes, one of the most versatile and virulent human pathogen, was initiated and high resolution crystallographic structures of native and DHAP-liganded TBP aldolase were solved. These structures allowed us to gain informations regarding active site residues implicated in catalysis and that give rise to the apparent lack of specificity. Soaking of TBP aldolase crystals in saturating DHAP solution specifically trapped the iminium intermediate, as demonstrated by its geometry. Furthermore, proton transfer studies uncovered an interesting phenomenon: TBP aldolase from S. pyogenes is unable to detritiate pro-R labelled hydrogen position at C3 of DHAP, yet it is able to tritiate both the pro-R and the pro-S position. These results, taken together with the superposition of the DHAP-TBP aldolase with the DHAP-FBP aldolase from rabbit muscle, suggest a cis-trans isomerism about the Schiff base C2-C3 bond. The resolution of both the native and the liganded structure also proved useful in identifying three very mobile regions in the protein. This trend could be linked to the putative metabolic sensor and genetic expression regulator role of LacD.1 in S. pyogenes. X-rays crystallography and traditional enzymatic kinetics allowed us to gain insights into the catalytic mechanism and others structural properties of this important metabolic enzyme.
50

Análise in vitro da capacidade de cobertura da vacina em desenvolvimento contra  Streptococcus pyogenes / \"in vitro\" analysis of the coverage capacity of the vaccine under development against most frequent strains of Streptococcus pyogenes

Karine Marafigo De Amicis 08 May 2013 (has links)
O Streptococcus pyogenes (Grupo A de Lancefield) é uma bactéria Gram positiva e beta-hemolítica, responsável por infecções, tais como Faringite, Sepse, Fasciíte Necrotizante e Síndrome do Choque Tóxico Estreptocócico. Indivíduos suscetíveis podem desenvolver sequela não supurativa auto-imune pós-estreptocócica, como a Febre Reumática, Doença Reumática Cardíaca e a Glomerulonefrite Aguda. A proteína M é o principal antígeno bacteriano. Consiste em aproximadamente 450 resíduos de aminoácidos dispostos em quatro regiões (A, B, C e D), contendo alguns blocos de repetições. As regiões C e D são conservadas e a N-terminal (regiões A e B) é polimórfica. Atualmente, existem mais de 250 genótipos de emm conhecidos em todo o mundo, de acordo com o Centers for Disease Control and Prevention. Há vários anos, o desenvolvimento de uma vacina contra S. pyogenes (StreptInCor - identificação médica) foi iniciado, com base na região conservada da proteína M, com o objetivo de proteger o indivíduo vacinado contra infecções estreptocócicas, sem causar reações autoimunes. No presente estudo foi analisada a capacidade \"in vitro\" de anticorpos anti-StreptInCor neutralizarem/opsonizarem as cepas de S. pyogenes mais freqüentes em São Paulo, através da análise do reconhecimento das cepas por soros de camundongos imunizados com StreptInCor. Também foi avaliada por Western blotting a presença de anticorpos de reação cruzada dirigidos ao tecido cardíaco valvular humano. Anticorpos anti-StreptInCor foram capazes de neutralizar/opsonizar, pelo menos, cinco diferentes cepas mostrando que a imunização com StreptInCor pode ser eficaz contra várias cepas de S. pyogenes, assim como prevenir a infecção e sequelas subsequentes, sem causar reações auto-imunes. / Streptococcus pyogenes (Group A) is a Gram positive and beta-hemolytic bacteria, responsible for infections such as Pharyngitis, Sepsis, Necrotizing Fasciitis and Streptococcal Toxic Shock Syndrome. Susceptible individuals may develop post-streptococcal non-suppurative autoimmune sequelae such as Rheumatic Fever, Rheumatic Heart Disease and Acute Glomerulonephritis. The M protein is the major bacterial antigen. It consists of approximately 450 amino acid residues arranged in four regions (A, B, C and D), containing some repeated blocks. C and D regions are conserved and the N-terminus (regions A and B) is polymorphic. Currently there are over 250 known emm genotypes worldwide, according to the Centers for Disease Control and Prevention. Several years ago the development of a vaccine against S. pyogenes (StreptInCor - medical identification) was initiated, based on the M protein conserved region, aiming to protect against streptococcal infections without causing autoimmune reactions. In the present study we analyzed the \"in vitro\" ability of anti-StreptInCor antibodies to neutralize/opsonize the most frequent S. pyogenes strains in Sao Paulo by examining the strains recognition by sera from StreptInCor immunized mice. We also evaluated the presence of cross reactive antibodies directed to the human heart valve tissue by Western blotting. Anti-StreptInCor antibodies were able to neutralize/opsonize at least 5 strains, showing that the immunization with StreptInCor can be effective against several S. pyogenes strains as well as preventing infection and subsequent sequelae, without causing autoimmune reactions.

Page generated in 0.0779 seconds